Abstract: A piston limiting structure, including: a cylinder, a piston, and a flange provided with a limiting piece, the cylinder has a piston hole perpendicular to an axial direction of the cylinder and penetrating through the cylinder, and a projection of the piston hole in a penetrating direction is circular. The piston is disposed in the piston hole in a form-fit manner and is slid in the piston hole in a reciprocating manner. A side wall of the piston is provided with a thrust groove, a bottom surface of the thrust groove forms a thrust surface on the side wall of the piston, and the thrust groove does not penetrate through two ends of the side wall of the piston along an axial length of the piston. The limiting piece abuts against the thrust surface.

Abstract: The present disclosure provides a pump body assembly, a heat exchange apparatus, a fluid machine and an operating method thereof. The pump body assembly includes a piston, a shaft, a piston sheath, and a cylinder. The shaft drives the piston to rotate and reciprocate within the piston sheath while rotating. The piston sheath is located in the cylinder, and a compression chamber is defined between an outer circumferential wall of the piston and an inner wall of the cylinder. A pressure relief recess is defined in the outer circumferential wall of the piston or the inner wall of the cylinder at a position corresponding to the compression chamber.

Abstract: The present invention generally relates to electrolytes for use in various electrochemical devices. In some cases, the electrolytes are relatively safe to use; for example, the electrolytes may be resistant to overheating, catching on fire, burning, exploding, etc. In some embodiments, such electrolytes may be useful for certain types of high-voltage cathode materials. In some cases, the electrolytes may include ion dissociation compounds that can dissociate tight ion pairs. Non-limiting examples of ion dissociation compounds include trialkyl phosphates, sulfones, or the like. Other aspects of the invention are generally directed to devices including such electrolytes, methods of making or using such electrolytes, kits including such electrolytes, or the like.

Abstract: A split-type hard front axle includes an axle housing; an axle tube connected to the axle housing; an inner-C-forging located at an end of the axle tube for connecting with a kingpin knuckle; and a connection structure cooperated with the inner-C-forgoing, for detachably fixing the inner-C-forging on the axle tube. The axle tube is provided with a first angle adjustment structure. The inner-C-forging is provided with a second angle adjustment structure. The inner-C-forging is sleeved on the axle tube, and the connection structure is inserted into the axle tube, to fix the inner-C-forging on the axle tube. The first angle adjustment structure is capable of cooperating with different portions of the second angle adjustment structure to make the inner-C-forging have different installation angles on the axle tube, and a caster to pinion angle is different at inner-C-forging's different installation angles. A vehicle is also provided.

Abstract: A polymer solid electrolyte includes a crosslinked polymer or copolymer with a heterogenous or disordered polymer network synthesized from one or more crosslinkers, wherein at least one crosslinker has three or more polymerizable or crosslinkable terminals. In another embodiment, the crosslinked polymer or copolymer has a polymer network with topological defects. In one embodiment, the crosslinked polymer is not over-crosslinked. An electrochemical device with the crosslinked polymer or copolymer as electrolyte exhibits an improved electrochemical and safety performance In certain embodiment, the crosslinkers include a) tri-acrylates, and tetra-acrylates; b) modified tri-acrylates and tetra-acrylates; c) silanes and siloxanes; and d) triazinane-triones.

Abstract: The disclosure provides a primer pair for identifying a gene segment of a male-specific molecular marker of American shad (Alosa sapidissima). The gene segment has a nucleic acid sequence represented by SEQ ID NO: 2, and the primer pair has nucleic acid sequences represented by SEQ ID NO: 3 and SEQ ID NO: 4.

Abstract: Disclosed are various polymer solid electrolyte materials suitable for various electrochemical devices and methods for making or using the same. The polymer solid electrolyte comprises a crosslinked polymer from a polymer. Certain embodiments are generally directed to solid electrolytes having relatively high ionic conductivity and/or other mechanical or electrical properties, e.g., tensile strength or decomposition potential. Certain aspects include a polymer, a plasticizer, and an electrolyte salt. In some cases, the polymer for synthesizing the crosslinked polymer may exhibit certain structures such as: where R1 can be one of the following groups: where n is an integer between 1 and 10000, m is an integer between 1 and 5000, and R2 to R6 can each independently be one: selected from the group consisting of hydrogen, methyl, ethyl, phenyl, benzyl, acryl, epoxy ethyl, isocyanate, cyclic carbonate, lactone, lactam, and vinyl; and * indicates a point of attachment.

Abstract: Disclosed is an electrochemical cell having a polymer solid electrolyte comprising a polymer localized on surface of an electrode. In one aspect, the localized polymer physically decreases or prevents exposure of freshly cracked electrode to a flammable solvent under extreme conditions, thus leading to an improved safety profile of the cell. In one aspect, the disclosure provides a polymer solid electrolyte comprising a polymer localized on surface of an electrode. Methods for preparing the same are also disclosed.

Abstract: The present invention generally relates to various polymer solid electrolyte materials suitable for various electrochemical devices and methods for making or using the same. Certain embodiments of the invention are generally directed to solid electrolytes having relatively high ionic conductivity and/or other mechanical or electrical properties, e.g., tensile strength or decomposition potential. Certain aspects include a polymer, a plasticizer, and an electrolyte salt. In some cases, the polymer may exhibit certain structures such as: where R1 can be one of the following groups: where n is an integer between 1 and 10000, m is a integer between 1 and 5000, and R2 to R6 are each independently selected from the group consisting of hydrogen, methyl, ethyl, phenyl, benzyl, acryl, epoxy ethyl, isocyanate, cyclic carbonate, lactone, lactam, and vinyl; and * indicates a point of attachment.

Abstract: The present disclosure relates to compounds of Formula I: that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.

Abstract: The present invention generally relates to electrolytes for use in various electrochemical devices. In some cases, the electrolytes are relatively safe to use; for example, the electrolytes may be resistant to overheating, catching on fire, burning, exploding, etc. In some embodiments, such electrolytes may be useful for certain types of high-voltage cathode materials. In some cases, the electrolytes may include ion dissociation compounds that can dissociate tight ion pairs. Non-limiting examples of ion dissociation compounds include trialkyl phosphates, sulfones, or the like. Other aspects of the invention are generally directed to devices including such electrolytes, methods of making or using such electrolytes, kits including such electrolytes, or the like.

Abstract: This disclosure relates to method and system for visual inspection of rotating components. The method includes representing rotation cycles of a rotating component as spatial features based on video or image frames, ascertaining and/or evolving Hidden Markov Model (HMM) chains for the cycles, ascertaining a count of the rotating component in the frames and/or labelling the frames with ascertained states of the HMM chains.

Abstract: The present disclosure relates to a method for increasing an amount of air and/or oxygen passing through an airway of an individual, reducing airway restrictions in an individual, increasing airway patency and/or maintaining airway patency in an individual, decreasing snoring, obstructive sleep apnea, or a combination thereof, in an individual. The method may comprise stimulating at least four regions of the individual's neck, where two of the at least four regions of the individual's neck are anterior triangle regions on opposing sides of the individual's midline, and another two of the at least four regions of the individual's neck are anterior triangle regions on opposing sides of the individual's midline, posterior to the two of the at least four regions. The present disclosure also discusses related devices and systems.

Abstract: A non-transitory computer readable medium stores instructions executable by at least one electronic processor to perform a virtual classroom method including: providing a three-dimensional (3D) virtual reality (VR) classroom including a presentation in the VR classroom; receiving, from one or more gaze tracking sensors, gaze data related to a gaze of at least one participant in the VR classroom; determining attentiveness of the at least one participant to the presentation in the VR classroom based on the received gaze data; and adjusting a rendering of the VR classroom based on the determined attentiveness.

Abstract: A composition for forming an artificial sold electrolyte interphase (SEI) layer includes a polymer, an artificial SEI forming salt, and a solvent. The polymer and the artificial SEI forming salt are dispersed in the solvent.

Abstract: An article includes a polymer. The polymer includes a product of a crosslinking reaction including at least one cross-linker selected from the group consisting of: a) di-acrylates, tri-acrylates, and tetra-acrylates; b) modified tri-acrylates and tetra-acrylates; c) silanes and siloxanes; and d) triazinane-triones.

Abstract: The present invention generally relates to electrolytes for use in various electrochemical devices. In some cases, the electrolytes are relatively safe to use; for example, the electrolytes may be resistant to overheating, catching on fire, burning, exploding, etc. In some embodiments, such electrolytes may be useful for certain types of high-voltage cathode materials. In some cases, the electrolytes may include ion dissociation compounds that can dissociate tight ion pairs. Non-limiting examples of ion dissociation compounds include trialkyl phosphates, sulfones, or the like. Other aspects of the invention are generally directed to devices including such electrolytes, methods of making or using such electrolytes, kits including such electrolytes, or the like.

Abstract: A nutritional powder containing oligopeptide includes the following components by weight: oligopeptide powder 55-80%, fruit powder 5-30%, amino acid powder 0.5-5%, multivitamin powder 1.25-5%, mineral powder 0.25-3%, and compound sweetener powder 5-10%.

Abstract: The present disclosure relates to a method for increasing an amount of air and/or oxygen passing through an airway of an individual, reducing airway restrictions in an individual, increasing airway patency and/or maintaining airway patency in an individual, decreasing snoring, obstructive sleep apnea, or a combination thereof, in an individual. The method may comprise stimulating at least four regions of the individual's neck, where two of the at least four regions of the individual's neck are anterior triangle regions on opposing sides of the individual's midline, and another two of the at least four regions of the individual's neck are anterior triangle regions on opposing sides of the individual's midline, posterior to the two of the at least four regions. The present disclosure also discusses related devices and systems.

Abstract: The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.